Sofosbuvir, daclatasvir and ribavirin cures hepatitis C for most people with advanced cirrhosis or liver transplants
Grazoprevir/elbasvir highly effective in treatment-experienced and HIV-coinfected hepatitis C patients
Grazoprevir / elbasvir highly effective in previously untreated hepatitis C
Sofosbuvir/ledipasvir plus ribavirin shows high cure rate for hepatitis C patients with advanced liver disease
Merck HCV combination effective after failure of first generation of direct-acting antivirals
Merck HCV combination achieves 90% cure in advanced cirrhosis
Two interferon-free regimens show high HCV cure rates for people with HIV and HCV co-infection
AbbVie next-generation hepatitis C drugs look promising in early studies
Sofosbuvir/ledipasvir cures most previously treated hepatitis C patients with cirrhosis
